Response from GlaxoSmithKline
Publication
, Journal Article
Rockhold, F; Metz, A; Traber, P
Published in: British Journal of Psychiatry
June 2002
Duke Scholars
Published In
British Journal of Psychiatry
DOI
EISSN
1472-1465
ISSN
0007-1250
Publication Date
June 2002
Volume
180
Issue
06
Start / End Page
548 / 548
Publisher
Royal College of Psychiatrists
Related Subject Headings
- Psychiatry
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rockhold, F., Metz, A., & Traber, P. (2002). Response from GlaxoSmithKline. British Journal of Psychiatry, 180(06), 548–548. https://doi.org/10.1192/s0007125000161197
Rockhold, F., A. Metz, and P. Traber. “Response from GlaxoSmithKline.” British Journal of Psychiatry 180, no. 06 (June 2002): 548–548. https://doi.org/10.1192/s0007125000161197.
Rockhold F, Metz A, Traber P. Response from GlaxoSmithKline. British Journal of Psychiatry. 2002 Jun;180(06):548–548.
Rockhold, F., et al. “Response from GlaxoSmithKline.” British Journal of Psychiatry, vol. 180, no. 06, Royal College of Psychiatrists, June 2002, pp. 548–548. Crossref, doi:10.1192/s0007125000161197.
Rockhold F, Metz A, Traber P. Response from GlaxoSmithKline. British Journal of Psychiatry. Royal College of Psychiatrists; 2002 Jun;180(06):548–548.
Published In
British Journal of Psychiatry
DOI
EISSN
1472-1465
ISSN
0007-1250
Publication Date
June 2002
Volume
180
Issue
06
Start / End Page
548 / 548
Publisher
Royal College of Psychiatrists
Related Subject Headings
- Psychiatry
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences